FMR »

Diamedica Therapeutics shares owned by FMR

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by FMR from 13F filings

Historical chart of FMR investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by FMR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by FMR

Quarter filed Position value Share count Share price at filing
2025-09-30 $666 97 6.87

More positions owned by FMR

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Ge Aerospace Com New (GE)
Wells Fargo & Company (WFC)

View all positions for FMR

Top funds holding Diamedica Therapeutics

Omega Advisors
BlackRock
Millennium Management
Paragon Associates & Paragon Associates Ii Joint Venture
Geode Capital Management
Vanguard Group
First Manhattan
State Street Corporation
Bleichroeder
Northern Trust
Morgan Stanley
LPL Financial
Advisor Group Holdings
CI Private Wealth
Corient IA

View all funds holding Diamedica Therapeutics